Document is current
Any future updates will be listed below
-
Authors
Mountjoy, Edward https://orcid.org/0000-0002-0626-1821
Schmidt, Ellen M.
Carmona, Miguel
Schwartzentruber, Jeremy https://orcid.org/0000-0002-6183-2092
Peat, Gareth
Miranda, Alfredo
Fumis, Luca
Hayhurst, James
Buniello, Annalisa
Karim, Mohd Anisul
Wright, Daniel
Hercules, Andrew
Papa, Eliseo https://orcid.org/0000-0002-2467-7759
Fauman, Eric B. https://orcid.org/0000-0002-9739-0249
Barrett, Jeffrey C.
Todd, John A. https://orcid.org/0000-0003-2740-8148
Ochoa, David https://orcid.org/0000-0003-1857-278X
Dunham, Ian https://orcid.org/0000-0003-2525-5598
Ghoussaini, Maya https://orcid.org/0000-0002-2415-2143
-
Funding
Funding for this research was provided by:
Wellcome Trust (206194, 206194, 206194, 206194, 206194, 206194, 206194, 206194)
- License Information
-
More Information
Article History
Received: 21 August 2020
Accepted: 20 August 2021
First Online: 28 October 2021
Competing interests
: J.A.T. is a member of the GSK Human Genetics Advisory Board. E.B.F. is a full-time employee of and shareholder in Pfizer, Inc. E.P. was an employee of Biogen at the time of the work. E.P. is now an employee of AstraZeneca. The remaining authors do not have any competing interests.
